Literature DB >> 6281311

Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man.

B Davies, D Sudera, G Sagnella, E Marchesi-Saviotti, C Mathias, R Bannister, P Sever.   

Abstract

Cardiovascular responses to intravenous administration of norepinephrine and the properties of alpha receptors on platelets were compared in normal human subjects and subjects with multiple system atrophy (MSA) and sympathetic degeneration. All the subjects with MSA had low plasma norepinephrine concentrations (in the supine position) (0.42 +/- 0.09 nM, normal 3.47 +/- 0.58 nM), which did not increase on tilt. The pressor sensitivity of subjects with MSA to norepinephrine infusion was increased 10- to 20-fold, demonstrating denervation supersensitivity to adrenergic agonists. Analysis of alpha receptors was by binding of [3H]dihydroergocryptine to platelets. Results are shown as mean +/- standard error of the mean. In the MSA subjects, the number of alpha receptors (1,712 +/- 699 fmol/10(8) platelets) was about sevenfold greater than in normal subjects (224 +/- 21 fmol/10(8) platelets), and the affinity, as measured by the equilibrium dissociation constant (Kd), was similar in both groups (MSA subjects, 9.6 +/- 4.3 nM; normal subjects, 4 +/- 0.5 nM). These observations suggest that an increase in alphaadrenergic receptor numbers may account for the denervation supersensitivity to infused norepinephrine in patients with sympathetic degeneration. All the subjects with MSA had low levels of the endogenous adrenergic transmitter norepinephrine: the simultaneous increase in alpha adrenergic receptors supports the theory of agonist regulation of receptor numbers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281311      PMCID: PMC370131          DOI: 10.1172/jci110516

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  Reduced beta-adrenergic receptor concentrations in ageing man.

Authors:  D D Schocken; G S Roth
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

3.  Cardiovascular reflexes and biochemical responses in progressive autonomic failure.

Authors:  R Bannister; P Sever; M Gross
Journal:  Brain       Date:  1977-06       Impact factor: 13.501

4.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

5.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

6.  3H-Catecholamine binding to alpha-receptors in rat brain: enhancement by reserpine.

Authors:  D C U'Prichard; S H Snyder
Journal:  Eur J Pharmacol       Date:  1978-09-15       Impact factor: 4.432

7.  Degenerative diseases of the nervous system associated with autonomic failure.

Authors:  R Bannister; D R Oppenheimer
Journal:  Brain       Date:  1972       Impact factor: 13.501

8.  Diminished inotropic response of aged myocardium to catecholamines.

Authors:  E G Lakatta; G Gerstenblith; C S Angell; N W Shock; M L Weisfeldt
Journal:  Circ Res       Date:  1975-02       Impact factor: 17.367

9.  Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure.

Authors:  R Bannister; B Davies; E Holly; T Rosenthal; P Sever
Journal:  Brain       Date:  1979-03       Impact factor: 13.501

10.  Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards.

Authors:  B Davies; R Bannister; P Sever
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

View more
  22 in total

Review 1.  Causalgia, pathological pain, and adrenergic receptors.

Authors:  E R Perl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  New trends in the treatment of orthostatic hypotension.

Authors:  J Jordan
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Dysautonomia: perioperative implications.

Authors:  Hossam I Mustafa; Joshua P Fessel; John Barwise; John R Shannon; Satish R Raj; André Diedrich; Italo Biaggioni; David Robertson
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

4.  Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Jose Martinez; Horacio Kaufmann
Journal:  Neurology       Date:  2018-09-19       Impact factor: 9.910

5.  Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.

Authors:  Jens Jordan; Cyndya Shibao; Italo Biaggioni
Journal:  Clin Auton Res       Date:  2015-03-11       Impact factor: 4.435

Review 6.  Receptors: the materialization of a concept.

Authors:  E J Ariëns
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

7.  Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.

Authors:  P T Larsson; A Martinsson; G Olsson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 8.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

9.  Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

Authors:  M A Pfeifer; K Ward; T Malpass; J Stratton; J Halter; M Evans; H Beiter; L A Harker; D Porte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.

Authors:  J Mehlsen; C Stadeager; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.